| Name | Title | Contact Details |
|---|---|---|
Jessica Castro |
Associate Director, Benefits | Profile |
Maria Fico |
Director, Human Resources Business Partner | Profile |
Bill VanNewkirk |
Director, Talent Acquisition Seqirus/CO/RandD/Americas | Profile |
James Peterson |
Director R&D Project Management | Profile |
Greg Healy |
Sr. Director, Head of Global R&D Communications | Profile |
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster.
InflaRx (Nasdaq:IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany as well as Ann Arbor, Michigan. InflaRx is listed on the Nasdaq Global Select Market in the United States under the trading symbol “IFRX”.
Blaine Labs is a Santa Fe Springs, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Affordable RX is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Advanced Pipetting Systems is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.